Feature | January 12, 2012

Experts Offer Pointers for Optimizing Radiation Dose in Pediatric CT


January 12, 2012 — An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans. Approximately seven to eight million CT examinations are performed for various pediatric clinical indications per year in the United States.

Justification of clinical indication is the most important aspect of reducing radiation dose with CT scanning. A substantial number of pediatric CT scans lack appropriate justification or can be replaced with other imaging modalities with lower or no ionizing radiation, such as radiography, ultrasonography and magnetic resonance imaging (MRI), which can provide similar diagnostic information for some clinical conditions. 

“When not clinically indicated, not performing a CT examination is certainly the best radiation dose reduction strategy. However, when a CT scan is indicated, there are steps that can be taken to optimize the dose that children receive. It’s important that all imaging providers take these steps as indicated,” said Mannudeep K. Kalra, M.D., author of the article. 

Investigators from Massachusetts General Hospital, Harvard Medical School, in Boston, and Johns Hopkins University in Baltimore, reviewed practical strategies for reducing radiation dose associated with pediatric CT examinations. “Radiation dose reduction in children starts with the optimization of pediatric CT protocols,” said Mahadevappa Mahesh, MS, Ph.D., author of the article. “CT protocols should be strictly optimized on the basis of body size, body region, clinical indication and the availability of prior imaging.”

Additional steps include using a lower tube current and voltage, restricting the scan length to include only the region of interest and using new techniques of image post-processing and reconstruction.   

“Children are more sensitive to radiation-induced risks and need special attention. Therefore, while designing CT protocols, it is crucial to keep clinical indications, weight and prior available imaging in mind to optimize radiation dose,” said Mahesh.

 For more information: www.jacr.org, www.imagewisely.org, www.imagegently.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now